TIMOTHY COUCH: Open Payments
NPI 1285295113 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,378 in 53 payments from 12 companies in 2025. Trend: 2023 $669 · 2024 $1,979 · 2025 $17,378
Speaker / faculty: $13,839Food & beverage: $2,778Travel & lodging: $761
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $15,529 |
| Janssen Pharmaceuticals, Inc | 5 | $455 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $311 |
| Otsuka America Pharmaceutical, Inc. | 3 | $275 |
| Axsome Therapeutics, Inc. | 2 | $249 |
| Vanda Pharmaceuticals Inc. | 2 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Neurelis, Inc. | 1 | $95 |
| Lundbeck LLC | 1 | $24 |
Products named: UZEDY, CAPLYTA, INVEGA SUSTENNA, REXULTI, Auvelity, FANAPT, SPRAVATO, COBENFY.
Industry payments across KY — which companies pay providers there.
